Pharma Friday – Oct. 2, 2026

Published on October 2, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves First Treatment for MCT8 Deficiency On Sept. 28, the U.S. Food and Drug Administration (FDA) approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid […]

The post Pharma Friday – Oct. 2, 2026 appeared first on Endocrine News.

Continue reading on website
Other news

Reframing Failure: Regaining Momentum After Setbacks in the Lab

September 30, 2026
While so much work in the lab can be uncertain, one thing will always remain true: You will fail. But how you bounce back from that little “speed bump” is important for yourself and your research. Kavaljit Chhabra, MPharm, PhD, shares his tips for getting your “lab mojo” back. All of the sessions at ENDO […]The post Reframing Failure: Regaining Momentum After Setbacks in the Lab appeared first on